abstract |
A somatostatin type-1 receptor agonist is used in the manufacture of a medicament for the treatment of a vascular proliferation. The agonist is a somatostatin type-1 receptor agonist having a Ki of at less than 5nM for the somatostatin type-1 receptor and having a Ki for the type- 1 somatostatin that is at least 10 times less than its Ki for each of the somatostatin type-2, type-3, type-4 and type-5 receptors provided that the selective agonists of not. H-D-Phe-Phe-Phe- D-Trp-Lys-Tyr-Phe-The-NH2. |